Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
BMC Cancer|November 5, 2016
Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancementJennifer Connelly, Adília Hormigo, Nimish Mohilie, et al.CNS Oncology|March 7, 2020
Clinical response to pazopanib in a patient with endolymphatic sac tumor not associated with von Hippel-Lindau syndromeThomas Nelson, Jethro Hu, Serguei Bannykh, et al.CNS Oncology|July 12, 2023
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNSAndy Liu, Huda Alalami, Xuemo Fan, et al.Journal of Neuro-Oncology|July 3, 2017
Report of safety of pulse dosing of lapatinib with temozolomide and radiation therapy for newly-diagnosed glioblastoma in a pilot phase II studyAndrew Yu, Nadia Faiq, Stacey Green, et al.Journal of Neuro-Oncology|December 13, 2012
A phase II trial of oral gimatecan for recurrent glioblastomaJethro Hu, Patrick Y Wen, Lauren E Abrey, et al.Journal of Neurosurgery|August 28, 2012
Prognosis of patients with multifocal glioblastoma: a case-control studyChirag G Patil, Anthony Yi, Adam Elramsisy, et al.Plos One|April 6, 2012
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide eraChristine Carico, Miriam Nuño, Debraj Mukherjee, et al.Neuro-Oncology|November 2, 2012
High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide eraChirag G Patil, Miriam Nuño, Adam Elramsisy, et al.Scientific Reports|July 2, 2025
A phase 1 safety and feasibility trial of a ketogenic diet plus standard of care for patients with recently diagnosed glioblastomaL J Amaral, Gillian Gresham, Sungjin Kim, et al.Oncotarget|March 3, 2016
Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategiesJoanne Xiu, David Piccioni, Tiffany Juarez, et al.Pageof 3